Private Advisor Group
UTHR icon

Private Advisor Group’s United Therapeutics UTHR Stock Holding History

Private Advisor Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,400
Closed -$9.9K – 2511
2023
Q3 		$9.9K Buy
+4,400
New +$1.01M ﹤0.01% 2176

Other funds holding UTHR

Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Private Advisor Group's UTHR Position: Q3 2026 in Review

Private Advisor Group increased its United Therapeutics (UTHR) stake by 25% in Q3 2026, buying an estimated $177K and bringing the position to 1,730 shares worth $938K. The position accounts for ﹤0.01% of the portfolio, ranked #1708.

Private Advisor Group first reported a position in UTHR in Q3 2023 and has held it in 5 quarters since. 477 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Private Advisor Group held 1,730 shares of United Therapeutics worth $938K as of Q3 2026.
  • Private Advisor Group bought 342 United Therapeutics shares in Q3 2026, an estimated $177K.
  • United Therapeutics made up ﹤0.01% of Private Advisor Group's portfolio in Q3 2026, its #1708 holding.
  • Private Advisor Group first reported a position in United Therapeutics in Q3 2023 and has held it in 5 quarters since.
  • 477 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Private Advisor Group's 13F filing for Q3 2026, filed 10 Nov 2026.